Pilot shows cross-Europe drug tracing; Aseptic facility up and running;

> A pharma pilot shows that full traceability systems within an open, cross-border supply chain is feasible across Europe, says the BRIDGE industry group. An overview video is available. Report

> Isogen's new 20,000-square-foot science center, a contract aseptic filling and manufacturing facility in Delaware, has successfully completed its media fills and has begun fulfilling a backlog of customer orders. Announcement

> Contract packager Compass Pharma Services has completed capital improvements upgrading its production capabilities to ISO Class 8, for such potent compounds as enzymes, antibiotics, antifolates, antimetabolites and some hormones. Release

> AAI Pharma's pharmaceutical development division has been acquired by Water Street Healthcare Partners, a private-equity concern that plans to invest $75 million in the contract manufacturer, renamed AAIPharma Services Corp. Article

> An internal report from generics maker Mylan says that the practice of overriding safety and efficacy quality control measures was "pervasive" and had occurred during the three shifts running at the West Virginia facility. Article

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.